Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>In the Q1 2024 earnings, CVS Health is experiencing both positive and negative impacts on its business structure.</li><li>The company reported lower-than-expected earnings per share of $1.31 due to significant utilization pressures in the Medicare Advantage, largely impacting its Health Care Benefits segment.</li><li>Due to these results and revised expectations for the rest of 2024, CVS has lowered full-year guidance for adjusted EPS to at least $7.</li></ul>

In the Q1 2024 earnings, CVS Health is experiencing both positive and negative impacts on its business structure.The company reported lower-than-expected earnings per share of $1.31 due to significant utilization pressures in the Medicare Advantage, largely impacting its Health Care Benefits segment.Due to these results and revised expectations for the rest of 2024, CVS has lowered full-year guidance for adjusted EPS to at least $7.

CVS Health Corporation: Will The  Increasing Margin in Medicare Advantage Last? - Major Drivers

<ul><li>Analyzing the latest earnings call transcript of CVS Health, it becomes evident that the company has managed to successfully navigate through a challenging environment and deliver on its financial commitments, underscoring the strength of its diversified business model.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li><li>In this report, we have carried out a fundamental analysis of the historical financial statements of the company.</li></ul>

Analyzing the latest earnings call transcript of CVS Health, it becomes evident that the company has managed to successfully navigate through a challenging environment and deliver on its financial commitments, underscoring the strength of its diversified business model.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

CVS Health Corporation: Integration Of Acquired Businesses

<ul><li>CVS Health Corporation managed to exceed analyst expectations in terms of revenue as well as earnings.</li><li>CVS Health demonstrated its integrated model's prowess, demonstrating significant progress in restoring its Medicare Advantage Star rating.</li><li>The Pharmacy & Consumer Wellness segment achieved nearly $29 billion in revenues, with the retail pharmacy business demonstrating robust performance.</li></ul>

CVS Health Corporation managed to exceed analyst expectations in terms of revenue as well as earnings.CVS Health demonstrated its integrated model's prowess, demonstrating significant progress in restoring its Medicare Advantage Star rating.The Pharmacy & Consumer Wellness segment achieved nearly $29 billion in revenues, with the retail pharmacy business demonstrating robust performance.

CVS Health Corporation: Medicare Advantage Pressures & Mitigation Strategies! - Major Drivers

<ul><li>CVS Health Corporation exceeded the revenue and earnings expectations of Wall Street, achieving key milestones in its strategy to deliver superior health experiences.</li><li>The acquisitions of Signify Health and Oak Street Health have strengthened its position in value-based care, and efforts to connect these assets with CVS Health's existing offerings are expected to accelerate growth.</li><li>We give CVS Health Corporation a 'Buy' rating with a revised target price.</li></ul>

CVS Health Corporation exceeded the revenue and earnings expectations of Wall Street, achieving key milestones in its strategy to deliver superior health experiences.The acquisitions of Signify Health and Oak Street Health have strengthened its position in value-based care, and efforts to connect these assets with CVS Health's existing offerings are expected to accelerate growth.We give CVS Health Corporation a 'Buy' rating with a revised target price.

CVS Health Corporation: 5 Key Growth Factors Every Investor Must Know! – Major Drivers

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>On 31 January, <a href="https://www.smartkarma.com/entities/walmart-inc" target="_blank" data-smartkarma-citation="entities:11134:1" rel="noopener">Walmart (WMT US)</a> announced a 3:1 stock split. For cognoscenti, that meant a Dow Jones Industrial Avg might be in the offing.</li>
<li>The last change to the index was in Aug-2020, spurred by the 4:1 split for <a href="https://www.smartkarma.com/entities/apple-inc" target="_blank" data-smartkarma-citation="entities:666:1" rel="noopener">Apple (AAPL US)</a>. This time, the likely deletion candidate was <a href="https://www.smartkarma.com/entities/walgreens-boots-alliance-inc" target="_blank" data-smartkarma-citation="entities:1118:1" rel="noopener">Walgreens Boots Alliance (WBA US)</a>. </li>
<li>Indeed, last week, the Index Keepers announced <a href="https://www.smartkarma.com/entities/amazon-com-inc" target="_blank" data-smartkarma-citation="entities:409:1" rel="noopener">Amazon.com Inc (AMZN US)</a> would replace Walgreens Boots Alliance on 26 Feb (i.e. WBA would be booted on the close of 23 Feb).</li>
</ul>


On 31 January, Walmart (WMT US) announced a 3:1 stock split. For cognoscenti, that meant a Dow Jones Industrial Avg might be in the offing.
The last change to the index was in Aug-2020, spurred by the 4:1 split for Apple (AAPL US). This time, the likely deletion candidate was Walgreens Boots Alliance (WBA US). 
Indeed, last week, the Index Keepers announced Amazon.com Inc (AMZN US) would replace Walgreens Boots Alliance on 26 Feb (i.e. WBA would be booted on the close of 23 Feb).


Walgreens Boots Alliance (WBA US) - How Do Dow Jones Deletes Do Historically?

United States

CVS Health Corporation is an integrated pharmacy health care provider. The Company's offerings include pharmacy benefit management services; mail order, retail and specialty pharmacy; disease management programs; and retail clinics. The company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Cvs Health Corp (CVS US)

CVS Health Corporation: Will The Increasing Margin in Medicare Advantage Last? - Major Drivers

In the Q1 2024 earnings, CVS Health is experiencing both positive and negative impacts on its business structure. The company reported...

Baptista Research

CVS Health Corporation: Integration Of Acquired Businesses

Analyzing the latest earnings call transcript of CVS Health, it becomes evident that the company has managed to successfully navigate through a...

Baptista Research

CVS Health Corporation: Medicare Advantage Pressures & Mitigation Strategies! - Major Drivers

CVS Health Corporation managed to exceed analyst expectations in terms of revenue as well as earnings. CVS Health demonstrated its integrated...

Baptista Research

CVS Health Corporation: 5 Key Growth Factors Every Investor Must Know! – Major Drivers

CVS Health Corporation exceeded the revenue and earnings expectations of Wall Street, achieving key milestones in its strategy to deliver superior...

Baptista Research

Walgreens Boots Alliance (WBA US) - How Do Dow Jones Deletes Do Historically?

Walgreens was given the boot from the Dow Jones Industrial Average on Friday at the close. Historically, DELETEs outperform their ADDs and DJIA in...

Travis Lundy

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)